What You Need to Know About Hormone Replacement Therapy (HRT) With Dr. Sharon Malone
May 25, 2022
Hormone Therapy 101May 25, 2022
Hormone Therapy 101For two decades, many women have been told that hormone therapy is too risky to consider. A lot of that fear goes back to 2002, when early findings from the Women's Health Initiative were reported widely, and prescriptions dropped almost overnight.
On The Tamsen Show, board-certified OB-GYN and certified menopause practitioner Dr. Sharon Malone walked through why that moment still shapes the conversation, and what later research has added. The short version: hormone therapy is not right for every woman, and it is not as simple as the headlines made it sound.
The Women's Health Initiative was a large study, and it changed practice quickly. Dr. Malone explained that much of the early coverage focused on breast cancer risk and left out important context, including the age of the women in the trial. Many participants were well past the typical start of menopause.
Later analyses looked more closely at women who started hormone therapy before age 60, or within 10 years of menopause. That timing is now central to how major medical organizations talk about benefits and risks.
The average age of menopause is 51. For healthy women who start treatment before age 60, or within 10 years of menopause, The Menopause Society and other medical groups say hormone therapy remains the most effective treatment for bothersome hot flashes and night sweats, and that the benefit-risk balance is often favorable. It can also help protect bone density.
Dr. Malone encouraged women not to wait through years of difficult symptoms on the assumption that starting later is safer. Timing matters, and so does your own health history. Starting later than that window is not automatically off the table, but it is a more individualized discussion with a clinician.
If you have a uterus, estrogen is usually combined with a progestogen to protect the uterine lining. If you have had a hysterectomy, estrogen-only therapy may be an option. Dr. Malone described menopausal hormone therapy as a lower dose than a typical birth control pill, used to ease symptoms rather than to recreate the hormone levels of your 20s or 30s.
Hormone therapy comes in several forms, including pills, patches, and other transdermal options. Dr. Malone noted that some of the clot concerns associated with hormone therapy were based on oral estrogen, and that transdermal estrogen appears to have less effect on clotting factors. That difference is one reason many clinicians discuss patches or other skin-based options, especially for women with certain risk factors. The right form still depends on your history.
Hormone therapy is not a treatment for everything that changes in midlife, and it is not risk-free. The Menopause Society is clear that the risk of breast cancer associated with estrogen-containing therapy is low, but it cannot be said that the risk is zero. Systemic hormone therapy is generally not recommended after breast cancer, with rare exceptions that should be made with a woman's full care team.
A family history of breast cancer is also not a simple yes-or-no on its own. Dr. Malone's view is that this should be a conversation about your goals, your risk tolerance, and your options, not a door that closes before anyone looks at the details.
You can hear the full conversation in the episode Is Hormone Therapy Safe? The Menopause Debate, Explained.
The information provided in this article is for educational and informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional regarding any medical concerns or treatment options. The views expressed by guests are their own and do not necessarily reflect those of The Tamsen Show.